Autoradiographic localization and computerized quantification of alpha 1- and alpha 2-adrenoceptors in spontaneously hypertensive rat kidney: [3H]bunazosin and [3H]yohimbine binding studies. 1991

K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
Third Department of Internal Medicine, Okayama University Medical School, Japan.

The autoradiographic localization of alpha 1- and alpha 2-adrenoceptors was identified in 22-week-old Wistar-Kyoto rat kidney, using alpha 1-selective ([3H]bunazosin) and alpha 2-selective ([3H]yohimbine) antagonists. [3H]Bunazosin binding was distributed predominantly over the cortex, less over the outer medulla and was absent from the inner medulla. [3H]Yohimbine binding was distributed predominantly over the medulla, less over the renal cortex and was absent from the inner medulla. In addition, the distribution of renal alpha-adrenoceptors was investigated in 3-, 7- and 22-week-old spontaneously hypertensive rats (SHRs) using a computerized image analysis system. Renal alpha-adrenoceptors were both found to be increased in SHRs at all ages tested compared with their respective controls and were increased in both the cortex and the outer medulla. The increase in renal alpha-adrenoceptors was already present in 3-week-old SHRs whose systolic blood pressures did not differ significantly from those of the controls. The results strongly suggest that these abnormalities of renal alpha-adrenoceptors may play a critical role in the development of hypertension in SHRs.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography

Related Publications

K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
January 2008, Pharmacological reports : PR,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
April 1986, European journal of pharmacology,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
January 1989, Journal of affective disorders,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
January 1986, European journal of pharmacology,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
June 1986, The Journal of pharmacology and experimental therapeutics,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
March 1983, European journal of pharmacology,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
May 1984, Biochemical and biophysical research communications,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
December 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
October 1982, European journal of pharmacology,
K Takatori, and T Ogura, and E Katayama, and Z Ota, and K Mizukawa, and N Ogawa
January 1985, Clinical science (London, England : 1979),
Copied contents to your clipboard!